.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
McKesson
US Army
Cipla
Fuji
Express Scripts
Merck
Moodys
Deloitte
Johnson and Johnson

Generated: June 26, 2017

DrugPatentWatch Database Preview

Hydrochlorothiazide; metoprolol tartrate - Generic Drug Details

« Back to Dashboard

What are the generic sources for hydrochlorothiazide; metoprolol tartrate and what is the scope of hydrochlorothiazide; metoprolol tartrate patent protection?

Hydrochlorothiazide; metoprolol tartrate
is the generic ingredient in two branded drugs marketed by Us Pharms Holdings I, Sun Pharm Inds, Alembic Pharms Ltd, and Mylan, and is included in four NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are thirty-one drug master file entries for hydrochlorothiazide; metoprolol tartrate. Six suppliers are listed for this compound.

Summary for Generic Name: hydrochlorothiazide; metoprolol tartrate

Tradenames:2
Patents:1
Applicants:4
NDAs:4
Drug Master File Entries: see list31
Suppliers / Packagers: see list6
Clinical Trials: see list581
Drug Prices:see low prices
DailyMed Link:hydrochlorothiazide; metoprolol tartrate at DailyMed

Pharmacology for Ingredient: hydrochlorothiazide; metoprolol tartrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan
METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; metoprolol tartrate
TABLET;ORAL076792-002Aug 20, 2004ABRXNoNo► Subscribe► Subscribe
Us Pharms Holdings I
LOPRESSOR HCT
hydrochlorothiazide; metoprolol tartrate
TABLET;ORAL018303-003Dec 31, 1984DISCNYesNo► Subscribe► Subscribe
Us Pharms Holdings I
LOPRESSOR HCT
hydrochlorothiazide; metoprolol tartrate
TABLET;ORAL018303-001Dec 31, 1984ABRXYesNo► Subscribe► Subscribe
Mylan
METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; metoprolol tartrate
TABLET;ORAL076792-001Aug 20, 2004ABRXNoNo► Subscribe► Subscribe
Sun Pharm Inds
METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; metoprolol tartrate
TABLET;ORAL090654-003Jan 19, 2012ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: hydrochlorothiazide; metoprolol tartrate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Us Pharms Holdings I
LOPRESSOR HCT
hydrochlorothiazide; metoprolol tartrate
TABLET;ORAL018303-002Dec 31, 19843,998,790► Subscribe
Us Pharms Holdings I
LOPRESSOR HCT
hydrochlorothiazide; metoprolol tartrate
TABLET;ORAL018303-003Dec 31, 19843,998,790► Subscribe
Us Pharms Holdings I
LOPRESSOR HCT
hydrochlorothiazide; metoprolol tartrate
TABLET;ORAL018303-001Dec 31, 19843,876,802► Subscribe
Us Pharms Holdings I
LOPRESSOR HCT
hydrochlorothiazide; metoprolol tartrate
TABLET;ORAL018303-002Dec 31, 19843,876,802► Subscribe
Us Pharms Holdings I
LOPRESSOR HCT
hydrochlorothiazide; metoprolol tartrate
TABLET;ORAL018303-003Dec 31, 19843,876,802► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Mallinckrodt
Dow
Healthtrust
Medtronic
Johnson and Johnson
Citi
Colorcon
Farmers Insurance
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot